相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Realgar and realgar-containing Liu-Shen-Wan are less acutely toxic than arsenite and arsenate
Jie Liu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
Comparative proteome study of apoptosis induced by As4S4 in retinoid acid resistant human acute promyelocytic leukemia NB4-R1 cells
Jun Qi et al.
LEUKEMIA RESEARCH (2010)
As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia
Jian-Hua Mao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
Jiong Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Roles of PI3-K/Akt pathways in nanoparticle realgar powders-induced apoptosis in U937 cells
Rong-gang Xi et al.
ACTA PHARMACOLOGICA SINICA (2008)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Mineral arsenicals in traditional medicines: Orpiment, realgar, and arsenolite
Jie Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding
Jin-Zhu Wu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report
DP Lu et al.
BLOOD (2002)
Arsenic trioxide: Mechanisms of action
K Davison et al.
SEMINARS IN HEMATOLOGY (2002)